Get an alert when TISSUE REGENIX HOLDINGS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

Latest balance sheet

Net assets

£28m

USD 38,066,000

+46.3% highest in 3 filed years

Employees

Average over period

Profit before tax

£8.9m

USD 12,041,000

+81.6% vs 2024

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover
Operating profit £7,484,950£3,403,196£7,542,921 +121.6%
Profit before tax £8,956,522£4,926,793£8,949,090 +81.6%
Net profit £8,956,522£4,926,793£8,949,090 +81.6%
Cash
Total assets less current liabilities £19,342,252£28,291,342 +46.3%
Net assets £14,415,459£19,342,252£28,291,342 +46.3%
Equity £14,415,459£19,342,252£28,291,342 +46.3%
Average employees
Wages
Directors' remuneration

Figures converted to GBP from USD at 0.743 per USD (Frankfurter spot rate) — hover any figure for the original. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Return on capital employed 17.6%26.7%
Gearing (liabilities / total assets) 66.2%57.4%0.2%

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
RSM UK Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors are satisfied that Tissue Regenix Group Limited is capable of providing the necessary financial support and that the Company, therefore, has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the Directors of the Company continue to adopt the going concern basis in preparing the financial statements.”

Group structure

  1. TISSUE REGENIX HOLDINGS LIMITED · parent
    1. Tissue Regenix Holdings Inc 100% · US · Holding company
    2. CellRight Technologies LLC 100% · US · Regenerative medicine

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 11 resigned

Name Role Appointed Born Nationality
LUND, Kirsten Mary Secretary 2019-12-20
LECOQUE, Jay Charles Director 2025-09-04 Nov 1962 American
LUND, Kirsten Mary Director 2025-10-16 Nov 1983 British
Show 11 resigned officers
Name Role Appointed Resigned
DEVLIN, Paul John Secretary 2017-04-10 2018-01-31
JONES, Gareth Hywel Secretary 2018-10-29 2019-12-20
BARKER, Michael Denis Director 2019-08-28 2019-11-30
COCKE, David Claiborne Director 2021-01-21 2025-07-31
COULDWELL, Steven Ashley Director 2017-11-15 2019-07-31
DEVLIN, Paul John Director 2017-04-10 2018-01-31
GLENN, Jonathan Martin Director 2020-04-01 2025-09-05
JONES, Gareth Hywel Director 2018-10-29 2020-11-24
LEE, Daniel Ray Director 2020-11-16 2025-10-15
ODELL, Antony Ruben Director 2017-04-10 2017-10-31
SAMUEL, John Andrew Walter Director 2017-04-10 2020-03-20

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Tissue Regenix Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2017-04-10 Active

Filing timeline

Last 20 of 49 total filings

Date Type Category Description
2026-07-12 AA accounts Accounts with accounts type full
2026-04-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-01-05 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-11-03 AP01 officers Appoint person director company with name date PDF
2025-11-03 TM01 officers Termination director company with name termination date PDF
2025-09-11 AP01 officers Appoint person director company with name date PDF
2025-09-11 TM01 officers Termination director company with name termination date PDF
2025-08-20 AA accounts Accounts with accounts type full
2025-08-04 TM01 officers Termination director company with name termination date PDF
2025-04-22 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-04-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-04-03 AA accounts Accounts with accounts type full
2023-04-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-03-28 AA accounts Accounts with accounts type full
2023-01-31 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-01-31 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2022-09-20 AA accounts Accounts with accounts type full
2022-04-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-09-25 AA accounts Accounts with accounts type full
2021-05-21 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
9

last 12 months

Capital events
0

last 24 months

Officers appointed
2

last 12 months

Officers resigned
2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page